NCT00519701
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Duke University Medican Center Durham, North Carolina, United States
Clinical trial condition
Anemia, Sickle Cell
Explore clinical trials studying Anemia, Sickle Cell. Study availability and eligibility vary by location and protocol.
843 public trials
154 recruiting studies
Anemia, Sickle Cell trial results
NCT00246077
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
- Locations
-
- The Children's Mercy Hospital Kansas City, Missouri, United States
NCT00456443
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
- Locations
-
- Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center Afula, Israel
NCT00005893
- Conditions
- Agranulocytosis, Anemia, Anemia, Aplastic, +26 more
- Locations
-
- Fairview University Medical Center Minneapolis, Minnesota, United States
NCT00005277
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
Not specified
NCT00004797
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
- Locations
-
Not specified
Active, Not Recruiting
TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
NCT05384756
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
NCT06155500
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Ctr New York, United States
- St Jude Childrens Research Hospital Memphis, Tennessee, United States
Active, Not Recruiting
Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease
NCT05675436
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
NCT03814746
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
- Locations
-
- Childrens Healthcare of Atlanta Atlanta, Georgia, United States
- Boston Medical Center Boston, Massachusetts, United States
- Levine Cancer Insitute Carolinas Healthcare System Charlotte, North Carolina, United States
- Univ of Tenn Health Sciences Ctr Memphis, Tennessee, United States